PluriSln 1

硬脂酰辅酶A去饱和酶抑制剂，可选择性消除hPSC（EC50=2µM），同时保留祖细胞和分化细胞；开发为一种策略，用于预防干细胞治疗期间使用的残留未分化细胞的致瘤风险。An inhibitor of stearoyl-CoA desaturase that selectively eliminates hPSCs (EC50 = 2 µM) while sparing progenitor and differentiated cells; developed as a strategy to prevent tumorigenic risk from residual undifferentiated cells used during stem cell therapy.